InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-11.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Shah Nikita, Président Exécutif. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 17 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. Activity tracked since 15 December 2021. The latest transaction was filed on 16 May 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
49,140 shares@ US$7.5830.7% of flowClass A Common StockSEC:0001628280-25-026513:0
36,232 sharesClass A Common StockSEC:0001628280-25-010678:0
28,958 sharesClass A Common StockSEC:0001628280-25-010113:0
100,000 shares@ US$7.7565.0% of flowClass A Common StockSEC:0001628280-24-037557:0
28,957 sharesClass A Common StockSEC:0001628280-24-008945:0
35,620 sharesClass A Common StockSEC:0001628280-24-007994:0
36,232 sharesClass A Common StockSEC:0001209191-23-016934:0
18,064 shares@ US$1.923.0% of flowClass A Common StockSEC:0001209191-23-016934:1
11,729 sharesClass A Common StockSEC:0001209191-23-015519:0
35,620 sharesClass A Common StockSEC:0001209191-23-014120:0
4,442 sharesClass A Common StockSEC:0001209191-22-028163:0
11,728 sharesClass A Common StockSEC:0001209191-22-016055:0
35,620 sharesClass A Common StockSEC:0001209191-22-014142:0
2,000 shares@ US$3.950.0002% mcap100.0% of flowClass A Common StockSEC:0001209191-21-070257
2,000 shares@ US$3.950.0002% mcap50.0% of flowClass A Common StockSEC:0001209191-21-070257:0
4,441 sharesClass A Common StockSEC:0001209191-21-031566
4,441 sharesClass A Common StockSEC:0001209191-21-031566:0
17 of 17 declarations
About Shah Nikita
Nikita Shah is Executive Vice President at Amneal Pharmaceuticals, Inc. She plays a key role in the strategic direction of the company, overseeing operations and contributing to innovation in the pharmaceutical sector.
